Resistant Bacterial Infections in the Early Post LDLT Period

Transplantation Infection Clinical Trial

Official title: Resistant Bacterial Infections in the Early Post LDLT Period

Status Completed

Clinical Trial Summary

The purpose of this work was to study the incidence, types, risk factors and causative organisms of bacterial infections in HCV Egyptian patients following Liver Transplantation. Moreover, to identify the emerging resistant strains and their proper antimicrobial therapy

Clinical Trial Description

This prospective descriptive study has been done at Tropical Medicine department in the period between January 2014 to November 2015.

After the approval of the scientific and ethical committee of Ain Shams University Hospital, Patients with HCV positive end stage liver disease (ESLD) eligible for liver transplantation Ain Shams Center for Organ Transplant (ASCOT); Ain Shams University, (fulfilling the inclusion criteria) were included in the current study. Forty five patients were recruited and each one was followed-up during a period of 3 months following transplantation.

Included patients were divided into 2 groups:

Group 1 included patients who had a postoperative single episode of infection. Group 2 included those patients who had more than 1 episode of postoperative bacterial infection whom were further evaluated for the presence of emerging strains and/or antibiotic resistance. ;

Related Conditions & MeSH terms

• Bacterial Infections
• Communicable Diseases
• Infection
• Transplantation Infection

• NCT number: NCT02777632
• Study type: Observational
• Source: Ain Shams University
• Status: Completed
• Phase: N/A
• Start date: January 2014
• Completion date: November 2015